TriSalus Life Sciences lays out therapeutic strategy upon acquisition of first therapeutic candidate

TriSalus Life Sciences lays out therapeutic strategy upon acquisition of first therapeutic candidate

DENVER and CHICAGO -- TriSalus Life Sciences (TriSalus), an emerging immune-oncology company committed to transforming outcomes for patients with solid tumors, announced its therapeutic clinical... Read More

Monday September 28, 2020 0 comments Tags: Westminster, TriSalus Life Sciences, SD-101, Mats Wahlstrom, Mary Szela, Steven Katz

Maxar awarded contract to build sixth geostationary communications satellite for Intelsat in 2020

Maxar awarded contract to build sixth geostationary communications satellite for Intelsat in 2020

WESTMINSTER -- Maxar Technologies (NYSE:MAXR) (TSX:MAXR) today announced it will build the Galaxy 37 geostationary communications satellite for Intelsat , operator of the world’s largest... Read More

Thursday September 17, 2020 0 comments Tags: Westminster, Maxar Technologies, Intelsat, Megan Fitzgerald

Cerapedics announces Canadian OK of its next-generation bone graft 

Cerapedics announces Canadian OK of its next-generation bone graft 

WESTMINSTER -- Cerapedics, a private ortho-biologics company, today announced Health Canada approval of the company's next-generation bone graft called i-FACTOR+ Matrix, making it the first market... Read More

Tuesday September 15, 2020 0 comments Tags: Westminster, Cerapedics, Glen Kashuba, Jeffrey Marx, i-FACTOR+Matrix

McClelland joins Maxar as VP of Mission Architecture

McClelland joins Maxar as VP of Mission Architecture

WESTMINSTER -- Maxar Technologies (NYSE:MAXR) (TSX:MAXR) today announced it has hired space industry veteran Jim McClelland to lead its newly established Mission Architecture function. In... Read More

Thursday August 13, 2020 0 comments Tags: Westminster, Maxar Technologies, Jim McClelland, Walter Scott

Cerapedics: FDA approves company's IDE supplement

Cerapedics: FDA approves company's IDE supplement

WESTMINSTER -- Cerapedics announced the U.S. Food and Drug Administration (FDA) has approved the company's Investigational Device Exemption (IDE) supplement, reducing the enrollment requirement for... Read More

Friday July 24, 2020 0 comments Tags: Westminster, Cerapedics, Jeffrey Marx, Glen Kashuba

Maxar renews four multi-million-dollar international defense, intel contracts

Maxar renews four multi-million-dollar international defense, intel contracts

WESTMINSTER -- Maxar Technologies (NYSE:MAXR) (TSX:MAXR) today announced it renewed four contracts and expanded a fifth contract in the second quarter of 2020–together valued at more than $120... Read More

Monday July 20, 2020 0 comments Tags: Westminster, Maxar Technologies, Tony Frazier

Flagship Biosciences launches new clinical diagnostics service

Flagship Biosciences launches new clinical diagnostics service

WESTMINSTER -- Flagship Biosciences, providers of expert tissue data insights, announced that the launch of a new clinical diagnostics immuno-oncology service, TissueInsight. TissueInsight... Read More

Monday July 6, 2020 0 comments Tags: Westminster, Flagship Biosciences, Trevor Johnson

Maxar Technologies completes acquisition of VA-based Vricon, Inc.

Maxar Technologies completes acquisition of VA-based Vricon, Inc.

WESTMINSTER -- Maxar Technologies (NYSE:MAXR) (TSX:MAXR) announced it has completed its previously announced acquisition of 3D data and analytics firm Vricon, Inc., for approximately $140 million,... Read More

Thursday July 2, 2020 0 comments Tags: Westminster, Maxar Technologies, Vricon